Skip to main content
Contact Us
Subscribe
E-Edition
39°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enovis Corporation Common Stock
(NY:
ENOV
)
43.89
+0.18 (+0.41%)
Official Closing Price
Updated: 7:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enovis Corporation Common Stock
< Previous
1
2
3
4
Next >
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
February 22, 2024
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Enovis Announces Fourth Quarter and Full Year 2023 Results
February 22, 2024
From
Enovis Corporation
Via
GlobeNewswire
Earnings Outlook For Enovis
February 21, 2024
Via
Benzinga
5 Analysts Have This To Say About Enovis
February 13, 2024
Via
Benzinga
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
February 12, 2024
From
Enovis Corporation
Via
GlobeNewswire
The Analyst Landscape: 6 Takes On Enovis
January 08, 2024
Via
Benzinga
Analyst Ratings for Enovis
December 15, 2023
Via
Benzinga
4 Analysts Have This to Say About Enovis
October 20, 2023
Via
Benzinga
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 07, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
January 29, 2024
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio.
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
January 26, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
January 25, 2024
The newest innovation in unloader braces is comfortable, easy to use and effective.
From
Enovis Corporation
Via
GlobeNewswire
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
January 03, 2024
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,...
Via
Benzinga
Enovis Completes Acquisition of LimaCorporate S.p.A
January 03, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From
Enovis Corporation
Via
GlobeNewswire
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
December 15, 2023
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising
Via
Benzinga
Enovis Announces Business Segment Leadership Transition Plan
December 05, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
November 16, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook
November 07, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting
October 30, 2023
Company unveils new ARVIS® augmented reality system, the EMPOWR™ blade stem and more at upcoming conference in Texas
From
Enovis Corporation
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
October 20, 2023
Via
Benzinga
ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028
October 20, 2023
From
Enovis Corporation
Via
GlobeNewswire
Why Enovis Stock Is Trading Lower Today
October 19, 2023
Enovis Corporation (NYSE: ENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of convertible senior notes and issued
Via
Benzinga
Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023
October 19, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes
October 19, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Third Quarter 2023 Results Conference Call on November 7th
October 16, 2023
From
Enovis Corporation
Via
GlobeNewswire
Big Moves In Orthopedics: Enovis Seals €800M Deal To Acquire LimaCorporate
September 25, 2023
Enovis Corp (NYSE: ENOV) inked a deal to acquire LimaCorporate S.p.A. for an
Via
Benzinga
Enovis to Acquire LimaCorporate S.p.A.
September 25, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
September 18, 2023
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and Patient Specific Instrumentation, will be featured as part of the company’s growing evidence based, high tech...
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
August 08, 2023
From
Enovis Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
